Cargando…

Antibody Persistence After Primary SARS-CoV-2 Infection and Protection Against Future Variants Including Omicron in Adolescents: National, Prospective Cohort Study

Antibodies are a measure of immunity after primary infection, which may help protect against further SARS-CoV-2 infections. They may also provide some cross-protection against SARS-CoV-2 variants. There are limited data on antibody persistence and, especially, cross-reactivity against different SARS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aiano, Felicity, Ireland, Georgina, Baawuah, Frances, Beckmann, Joanne, Okike, Ifeanyichukwu O., Ahmad, Shazaad, Garstang, Joanna, Brent, Andrew J., Brent, Bernadette, Borrow, Ray, Linley, Ezra, Ho, Sammy, Carr, Christine, Zambon, Maria, Poh, John, Warrener, Lenesha, Amirthalingam, Gayatri, Brown, Kevin E., Ramsay, Mary E., Hoschler, Katja, Ladhani, Shamez N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	COVID Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187624/ https://www.ncbi.nlm.nih.gov/pubmed/36916856 http://dx.doi.org/10.1097/INF.0000000000003890

Ejemplares similares

Emergence of SARS-CoV-2 Alpha (B.1.1.7) variant, infection rates, antibody seroconversion and seroprevalence rates in secondary school students and staff: Active prospective surveillance, December 2020 to March 2021, England
por: Ladhani, Shamez N., et al.
Publicado: (2021)

Emergence of the delta variant and risk of SARS-CoV-2 infection in secondary school students and staff: Prospective surveillance in 18 schools, England
por: Ladhani, Shamez N., et al.
Publicado: (2022)

Antibody persistence and neutralising activity in primary school students and staff: Prospective active surveillance, June to December 2020, England
por: Ireland, Georgina, et al.
Publicado: (2021)

SARS-CoV-2 infection, antibody positivity and seroconversion rates in staff and students following full reopening of secondary schools in England: A prospective cohort study, September–December 2020
por: Ladhani, Shamez N., et al.
Publicado: (2021)

SARS Antibody Testing in Children: Development of Oral Fluid Assays for IgG Measurements
por: Hoschler, Katja, et al.
Publicado: (2022)

Feasibility and acceptability of SARS-CoV-2 testing and surveillance in primary school children in England: Prospective, cross-sectional study
por: Aiano, Felicity, et al.
Publicado: (2021)

SARS-CoV-2 infection and transmission in primary schools in England in June–December, 2020 (sKIDs): an active, prospective surveillance study
por: Ladhani, Shamez N, et al.
Publicado: (2021)

Perceptions of adolescents on the COVID-19 pandemic and returning to school: qualitative questionnaire survey, September 2020, England
por: Powell, Annabel A., et al.
Publicado: (2022)

Implementation of preventive measures to prevent COVID-19: a national study of English primary schools in summer 2020
por: Sundaram, Neisha, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 antibodies in university students: Cross-sectional study, December 2020, England
por: Vusirikala, Amoolya, et al.
Publicado: (2021)

Serological responses to COVID-19 Comirnaty booster vaccine, London, United Kingdom, September to December 2021
por: Ireland, Georgina, et al.
Publicado: (2022)

Parents’ and teachers’ attitudes to and experiences of the implementation of COVID-19 preventive measures in primary and secondary schools following reopening of schools in autumn 2020: a descriptive cross-sectional survey
por: Amin-Chowdhury, Zahin, et al.
Publicado: (2022)

Secondary attack rates in primary and secondary school bubbles following a confirmed case: Active, prospective national surveillance, November to December 2020, England
por: Powell, Annabel A., et al.
Publicado: (2022)

Robust antibody responses in 70–80-year-olds 3 weeks after the first or second doses of Pfizer/BioNTech COVID-19 vaccine, United Kingdom, January to February 2021
por: Subbarao, Sathyavani, et al.
Publicado: (2021)

Author Correction: Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England
por: Amirthalingam, Gayatri, et al.
Publicado: (2022)

Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England
por: Amirthalingam, Gayatri, et al.
Publicado: (2021)

Large increases in SARS-CoV-2 seropositivity in children in England: Effects of the delta wave and vaccination
por: Oeser, Clarissa, et al.
Publicado: (2022)

Serological surveillance of SARS-CoV-2: Six-month trends and antibody response in a cohort of public health workers
por: Harris, Ross J., et al.
Publicado: (2021)

Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection
por: Dowell, Alexander C., et al.
Publicado: (2021)

Immunological imprinting of humoral immunity to SARS-CoV-2 in children
por: Dowell, Alexander C., et al.
Publicado: (2023)

mRNA or ChAd0x1 COVID-19 Vaccination of Adolescents Induces Robust Antibody and Cellular Responses With Continued Recognition of Omicron Following mRNA-1273
por: Dowell, Alexander C., et al.
Publicado: (2022)

Author Correction: Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection
por: Zuo, Jianmin, et al.
Publicado: (2021)

Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection
por: Zuo, Jianmin, et al.
Publicado: (2021)

Real-world data on immune responses following heterologous prime-boost COVID-19 vaccination schedule with Pfizer and AstraZeneca vaccines in England
por: Westrop, Samantha J, et al.
Publicado: (2022)

Antibodies to SARS-CoV-2 protect against re-infection during outbreaks in care homes, September and October 2020
por: Jeffery-Smith, Anna, et al.
Publicado: (2021)

Trends in laboratory-confirmed bacterial meningitis (2012–2019): national observational study, England
por: Subbarao, Sathyavani, et al.
Publicado: (2023)

COVID-19 vaccine given to children with comorbidities in England, December 2020–June 2021
por: Aiano, Felicity, et al.
Publicado: (2022)

Following the Omicron wave, the majority of children in England have evidence of previous COVID infection
por: Oeser, C, et al.
Publicado: (2023)

Serogroup C Neisseria meningitidis disease epidemiology, seroprevalence, vaccine effectiveness and waning immunity, England, 1998/99 to 2015/16
por: Findlow, Helen, et al.
Publicado: (2019)

Assessment of healthcare delivery in the early management of bacterial meningitis in UK young infants: an observational study
por: Okike, Ifeanyichukwu O, et al.
Publicado: (2017)

Risk of hospitalisation and death in children with SARS-CoV-2 delta (B.1.612.2) infection
por: Thelwall, Simon, et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 among Blood Donors and Changes after Introduction of Public Health and Social Measures, London, UK
por: Amirthalingam, Gayatri, et al.
Publicado: (2021)

Emergency Meningococcal ACWY Vaccination Program for Teenagers to Control Group W Meningococcal Disease, England, 2015–2016
por: Campbell, Helen, et al.
Publicado: (2017)

Factors associated with COVID-19 vaccine uptake in adolescents: a national cross-sectional study, August 2021–January 2022, England
por: Aiano, Felicity, et al.
Publicado: (2023)

Reinfection with new variants of SARS-CoV-2 after natural infection: a prospective observational cohort in 13 care homes in England
por: Jeffery-Smith, Anna, et al.
Publicado: (2021)

Serological surveillance of influenza in an English sentinel network: pilot study protocol
por: de Lusignan, Simon, et al.
Publicado: (2019)

COVID-19 in children: analysis of the first pandemic peak in England
por: Ladhani, Shamez N, et al.
Publicado: (2020)

Cross sectional investigation of a COVID-19 outbreak at a London Army barracks: Neutralising antibodies and virus isolation
por: Taylor, Hannah, et al.
Publicado: (2020)

Real-world data shows increased reactogenicity in adults after heterologous compared to homologous prime-boost COVID-19 vaccination, March−June 2021, England
por: Powell, Annabel A, et al.
Publicado: (2021)

Enter B and W: two new meningococcal vaccine programmes launched
por: Ladhani, Shamez N, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qsf0dgcl6mdfiup751jdobs4pe